Improvement of Therapeutic Effect via Inducing Non‐Apoptotic Cell Death Using mRNA‐Protection Nanocage
Advanced Healthcare Materials · 2024-10 · 13 (27)
DOI: 10.1002/adhm.202400240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 31.07.2024. Verfasst von Seoyoung Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomaterial Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea. Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinases, RNA, Messenger, Nanoparticles, Necroptosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Necroptosis, a cell death mechanism with the characteristics of both apoptosis and necrosis, is proposed as a promising therapeutic approach for cancer therapy. Induction of necroptosis for cancer therapy may be possible through the regulation of the expression of a key factor gene receptor‐interacting protein kinase‐3 (RIPK3) via in vitro transcription (IVT) mRNA delivery. However, mRNA is susceptible to degradation and has a low delivery efficiency, which highlights the requirement of a proper delivery vehicle for intracellular delivery. Therefore, a new mRNA delivery system based on the nanostructured silica nanoparticles, termed mRNA‐protective nanocage (mPN) has been developed. High‐efficiency expression of RIPK3 and induction of necroptosis is achieved through delivery of RIPK3 IVT mRNA with mPN in vitro and in vivo models. Importantly, the mPN carrying RIPK3 mRNA distributed locally in tumors upon intravascular injection, and successfully induced necroptosis and immune cell infiltration, a hallmark of necroptosis. the suppression of tumor growth in a murine cancer model, demonstrating the synergistic effect of RIPK3 mRNA‐ and immune cell‐mediated therapy is also observed. These findings suggest the potential for anticancer therapy through necroptosis induction and provide a strategy for the development of mRNA‐based nanomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomaterial Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
- Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
- College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju, Gyeongsangnam-do, 52828, Republic of Korea.
- Department of Biochemistry and Molecular Biology, Korea University College of Medicine, Seoul, 02841, Republic of Korea.
- BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, 02841, Republic of Korea.
- Division of Bio-Medical Science & Technology, Korea National University of Science and Technology (UST), Seoul, 02792, Republic of Korea.
ORCID-Profile: Nan-Ee Lee, Hyojin Lee
Förderung
- National Research Foundation of Korea
- Korea Health Industry Development Institute
Zitieren
APA
Kim, S., Kim, S., Kim, S., Lee, N. E., Lee, S. H., Kim, H., & Lee, H. (2024). Improvement of Therapeutic Effect via Inducing Non‐Apoptotic Cell Death Using mRNA‐Protection Nanocage. Advanced Healthcare Materials, 13(27). https://doi.org/10.1002/adhm.202400240
Vancouver
Kim S, Kim S, Kim S, Lee NE, Lee SH, Kim H, et al. Improvement of Therapeutic Effect via Inducing Non‐Apoptotic Cell Death Using mRNA‐Protection Nanocage. Advanced Healthcare Materials. 2024;13(27). doi:10.1002/adhm.202400240
BibTeX
@article{Kim2024,
author = {Kim, Seoyoung and Kim, Seongchan and Kim, Sojin and Lee, Nan-Ee and Lee, Soo-Hwan and Kim, Hyunkyung and Lee, Hyojin},
title = {Improvement of Therapeutic Effect via Inducing Non‐Apoptotic Cell Death Using mRNA‐Protection Nanocage},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {27},
doi = {10.1002/adhm.202400240}
}
EUVIMED